Beckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with next-generation sequencing (NGS) research solutions. Today the company announces a collaboration agreement with Pillar Biosciences, which develops and distributes IVD & RUO NGS testing solutions based on their proprietary SLIMamp® technology to help localize patient testing and optimize the selection of precision therapies for cancer patients.

MultiPlan Taps Healthcare Tech Veteran Travis Dalton as New CEO

Travis Dalton, CEO at MultiPlan Corporation (Joan Mateu Parra / Shooting) What You Should Know: – MultiPlan Corporation (NYSE: MPLN), a provider of data analytics

January 5, 2024

Biden’s Annual Physical Results Will Be Closely Watched as Election Nears

President Joe Biden is visiting Walter Reed National Military Medical Center on Wednesday for his annual physical exam — and the results are sure to

February 29, 2024

Ketamine variant shows promise in treating social impairments

Well-being is important for everyone, especially when we feel lonely or isolated. Depression is a serious challenge for many people and finding an effective solution

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.